![Kevin Moulder](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Kevin Moulder served as the Chief Development Officer at Tusk Therapeutics Ltd. from 2015 to 2018.
He then worked as the Chief Operating Officer at Polyprox Therapeutics Ltd. from 2018 to 2021.
In 2021, he became the Chief Scientific Officer at Medicenna Therapeutics Corp.
Dr. Moulder also held the position of Chief Scientific Officer at F-star Therapeutics Ltd. Dr. Moulder received a graduate and doctorate degree from the University of London.
Antiguos cargos conocidos de Kevin Moulder.
| Empresas | Cargo | Fin |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Director Técnico/Científico/I+D | 03/03/2022 |
Polyprox Therapeutics Ltd.
 Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases | Director de Operaciones | 01/02/2021 |
Tusk Therapeutics Ltd.
 Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/09/2018 |
F-star Therapeutics Ltd.
 F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops antibodies therapeutics for cancer therapy | Director Técnico/Científico/I+D | - |
Formación de Kevin Moulder.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
4
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tusk Therapeutics Ltd.
Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Medicenna Therapeutics Corp.
 Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Polyprox Therapeutics Ltd.
Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases | Health Technology |
F-star Therapeutics Ltd.
F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops antibodies therapeutics for cancer therapy | Health Technology |
- Bolsa de valores
- Insiders
- Kevin Moulder
